Machtakova Marina, Thérien-Aubin Héloïse, Landfester Katharina
Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
Department of Chemistry, Memorial University of Newfoundland, St. John's, NL, Canada.
Chem Soc Rev. 2022 Jan 4;51(1):128-152. doi: 10.1039/d1cs00686j.
Biomacromolecular therapeutic agents, particularly proteins, antigens, enzymes, and nucleic acids are emerging as powerful candidates for the treatment of various diseases and the development of the recent vaccine based on mRNA highlights the enormous potential of this class of drugs for future medical applications. However, biomacromolecular therapeutic agents present an enormous delivery challenge compared to traditional small molecules due to both a high molecular weight and a sensitive structure. Hence, the translation of their inherent pharmaceutical capacity into functional therapies is often hindered by the limited performance of conventional delivery vehicles. Polymer drug delivery systems are a modular solution able to address those issues. In this review, we discuss recent developments in the design of polymer delivery systems specifically tailored to the delivery challenges of biomacromolecular therapeutic agents. In the future, only in combination with a multifaceted and highly tunable delivery system, biomacromolecular therapeutic agents will realize their promising potential for the treatment of diseases and for the future of human health.
生物大分子治疗剂,特别是蛋白质、抗原、酶和核酸,正成为治疗各种疾病的有力候选药物,基于mRNA的新型疫苗的开发凸显了这类药物在未来医学应用中的巨大潜力。然而,与传统小分子相比,生物大分子治疗剂由于分子量高和结构敏感,在递送方面面临巨大挑战。因此,传统递送载体的有限性能常常阻碍它们将内在的药物能力转化为功能性疗法。聚合物药物递送系统是一种能够解决这些问题的模块化解决方案。在本综述中,我们讨论了专门针对生物大分子治疗剂递送挑战设计的聚合物递送系统的最新进展。未来,只有与多方面且高度可调的递送系统相结合,生物大分子治疗剂才能实现其在疾病治疗和人类健康未来方面的巨大潜力。